Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
-
AMN Healthcare Announces First Quarter 2024 Results
-
Jamf Announces Upcoming Conference Participation
-
VALHI REPORTS FIRST QUARTER 2024 RESULTS
-
CytoSorbents Reports First Quarter 2024 Results
-
Artisan Partners Asset Management Inc. Reports April 2024 Assets Under Management
-
Kodak Reports First-Quarter 2024 Financial Results
-
Oportun Reports First Quarter 2024 Financial Results
-
DIAGNOS Announces Closing of First Tranche of Private Placement
-
Tyson Foods Announces Quarterly Dividend
-
NI Holdings, Inc. Reports Results for First Quarter Ended March 31, 2024
-
DoubleDown Interactive to Participate at 19th Annual Needham Technology, Media & Consumer Conference on May 16
-
Cipher Mining to Participate in the 19th Annual Needham Technology, Media, & Consumer Conference
-
Rackspace Technology Reports First Quarter 2024 Results
-
Southside Bancshares, Inc. Declares Cash Dividend
-
Cipher Mining to Participate in the 19th Annual Needham Technology, Media, & Consumer Conference
-
Montauk Renewables Announces First Quarter 2024 Results
-
Pineapple Energy Reports First Quarter 2024 Financial Results
-
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
-
ESCO Reports Second Quarter Fiscal 2024 Results
-
DoubleDown Interactive to Participate at 19th Annual Needham Technology, Media & Consumer Conference on May 16
-
Applied Optoelectronics Reports First Quarter 2024 Results
-
Autoscope Technologies Corporation Announces Financial Results and Dividend Declaration
-
Sienna Senior Living Inc. Reports Strong First Quarter 2024 Financial Results and Moves Forward with Redevelopment of Long-Term Care Home in Keswick, Ontario
-
Brilliant Earth Reports First Quarter 2024 Results
-
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
TerrAscend Reports First Quarter 2024 Financial Results
-
Karat Packaging Reports 2024 First Quarter Financial Results
-
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
-
Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations
-
Getty Images Reports First Quarter 2024 Results
-
ACWA Honors East Valley Water District for its Innovative, Multi-Beneficial Wastewater Treatment Facility
-
Four California College Students Awarded ACWA Scholarships
-
Rigetti Computing Reports First Quarter 2024 Financial Results
-
Canterbury Park Holding Corporation Reports First Quarter Results
-
Americold Announces First Quarter 2024 Results
-
eGain Reports Continued Momentum in New Logo Wins Driven by AI Knowledge Offering
-
Aqua Metals to Announce First Quarter 2024 Financial Results and Host Investor Conference Call on May 15, 2024
-
Haynes International, Inc. Reports Second Quarter Fiscal 2024 Financial Results
-
Array Technologies, Inc. Reports Financial Results for the First Quarter 2024 – Achieves record gross margin and $2.1 billion of executed contracts and awarded orders
-
Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
-
Phunware Reports Significant Improvement in First Quarter 2024 Financial Results
-
Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold
-
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
-
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
-
Mobivity Schedules First Quarter 2024 Conference Call for Wednesday, May 15, 2024
-
Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
-
Synaptics Reports Third Quarter Fiscal 2024 Results
-
Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024

